TAVI: Edwards CEO says Sapien 3 could hit U.S. market this year
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-generation Sapien 3 replacement heart valve this year.
Edwards LifesciencesNews Well, MassDevice.com Earnings Roundup, 2015, Q1, Replacement Heart Valvesread more
Source: Mass Device - Category: Medical Equipment Authors: Brad Perriello Source Type: news
More News: Cardiology | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices